PRAXBIND

Google image searchProduct monograph

Active ingredient

idarucizumab, 50 MG/ML

DIN: 02454343

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: 5 G PER DOSE (2 X 2.5 G /50 ML)

Schedule: Prescription / Schedule D

Company: BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Date: 24-MAY-2016

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AB — Antidotes (ATC, ATC/DDD)
• V03AB37 — IDARUCIZIMAB (ATC/DDD)

External Links for Praxbind

Search on Google

• Praxbind side effects
• Praxbind dosage
• idarucizumab side effects
• idarucizumab dosage

Boehringer Ingelheim (Canada) Ltd Ltee

Go to Boehringer Ingelheim website to see drug product details. Sometimes you can find praxbind photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.